Selano, Jeffrey Lawrence – Trademark Portfolio

Entity Type: 01

Selano, Jeffrey Lawrence holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VIPER CELL and BATHROOM NINJA. The owner is based in Dallas, GA.

P.O. Box 949

Dallas, GA 30132

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Selano, Jeffrey Lawrence's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Selano, Jeffrey Lawrence have?

Selano, Jeffrey Lawrence has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Selano, Jeffrey Lawrence file in?

Selano, Jeffrey Lawrence files trademarks across 2 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 5 (Pharmaceuticals). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.

What are Selano, Jeffrey Lawrence's most well-known trademarks?

Selano, Jeffrey Lawrence's registered trademark portfolio includes well-known marks such as VIPER CELL and BATHROOM NINJA. These are among 2 currently registered trademarks in the portfolio.

What is Selano, Jeffrey Lawrence's trademark registration success rate?

Selano, Jeffrey Lawrence has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.